Mayo clinic tests 'Zombie Cell' cleaners for Alzheimer's
NCT ID NCT04785300
Summary
This small, early-stage study is testing whether two drugs (Dasatinib and Quercetin) can be safely given to people with Alzheimer's disease or mild cognitive impairment. The drugs aim to clear out 'senescent' or aging cells that may contribute to brain decline. Researchers will monitor 20 participants over 55 for side effects and how well they tolerate the treatment regimen.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes NO responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for ALZHEIMER DISEASE are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Locations
-
Mayo Clinic in Rochester
Rochester, Minnesota, 55905, United States
Conditions
Explore the condition pages connected to this study.